JPRN-jRCT2080223317未知2 期
A Multi-center, Randomized, Double-blind, Vehicle-controlled, Parallel-group Comparison Trial to Assess the Efficacy and Safety of OPA-15406 Ointment in Patients With Atopic Dermatitis
适应症
试验速览
- 阶段
- 2 期
- 入组人数
- 180
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- >= 15age old 至 <= 70age old（—）
- 性别
- All
入选标准
- •Diagnosis of atopic dermatitis based on the criteria of Hanifin and Rajka
排除标准
- •- Subjects who have an atopic dermatitis or contact dermatitis flare-up defined as a sudden intensification of atopic dermatitis.
- •- Subjects who have an active viral skin infection.
- •- Subjects with a current or history of malignancy.
研究者
相似试验
进行中（未招募）
1 期
Study to test the safety and efficacy of using both Benzoyl peroxide/ Clindamycin gel and Tazarotene cream in combination to treat Acne.EUCTR2015-004900-44-Outside-EU/EEAGlaxoSmithKline Research & Development591
进行中（未招募）
不适用
A randomized, double-blind, multi-center, vehicle-controlled, parallel group study to evaluate the efficacy and safety of diclofenac diethylamine 2.32% gel applied once or twice daily in subjects with acute ankle spraiacute ankle sprainMedDRA version: 9.1Level: LLTClassification code 10002549Term: Ankle sprainEUCTR2007-003797-25-DEovartis Consumer Health SA
招募中
2 期
A clinical trial to study the effects of two concentrations of povidone-iodine nail solution to be applied locally on nail for the treatment of nail bed infection due to chemotherapy treatment in cancer patients.CTRI/2017/11/010647Joseph Capriotti
进行中（未招募）
1 期
Study of Topical Application of a Gel Containing the Investigational Active Ingredient Patidegib versus the same Gel Without Patidegib (Placebo) for the Prevention of New Facial Skin Tumors (Basal Cell Carcinomas) in People with Gorlin Syndrome.EUCTR2018-001462-42-ITPellePharm, Inc.150
未知
2 期
A Multicenter, Randomized, Double-blind, Vehicle-controlled, Parallel-group Trial to Assess the Safety and Efficacy of 0.3% and 1% OPA-15406 Ointments When Administered for 4 Weeks in Pediatric Patients With Atopic DermatitisAtopic DermatitisJPRN-jRCT2080223429Otsuka Pharmaceutical Co., Ltd.60